Centene Corporation (CNC)
What changed in recent filings
- Medicare segment 13% → 21%Sep 30, 2024 → Jun 30, 2026
- Institutions — 4 new · 1 added · 4 reduced13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Institutions holding Centene Corporation
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 6 → 2026 Q2: 9 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold Centene Corporation
Institutions we track that reported holding this stock in their most recent 13F.
- Bridgewater Associates0.10% of portfolio · since 2022 Q1
- Greenlight Capital2.71% of portfolio · since 2024 Q4
- Glenview Capital Management2.20% of portfolio · since 2025 Q3
- Tudor Investment Corp0.02% of portfolio · since 2025 Q4
- Point72 Asset Management0.05% of portfolio · since 2026 Q1
- Caisse de depot (Quebec)0.13% of portfolio · held as of 2026 Q2 or earlier
- National Pension Service (Korea)0.04% of portfolio · held as of 2026 Q2 or earlier
- Harris Associates (Oakmark)0.95% of portfolio · held as of 2026 Q2 or earlier
- Capital World Investors0.01% of portfolio · held as of 2026 Q2 or earlier
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Company overview
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Centene Corporation is classified under the Biotech & Health sector. See peers below.
CNC segment revenue mix trend
Quarterly change in segment revenue share · verified from SEC filings
ETFs holding Centene Corporation
Per SEC N-PORT · 2026-06-30 · by weight · factual
CNC on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
CNC FAQ
What is Centene Corporation (CNC)?
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
What sector is Centene Corporation in?
Centene Corporation is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
Where can I analyze Centene Corporation (CNC) stock?
On Stocklore you can see CNC's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.